Exane Derivatives’s Hanesbrands HBI Stock Holding History

Exane Derivatives’s Portfolio HBI Stock Details HBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-51	Closed	-$769	–	849
2020 Q3	$803	Sell	51 -171,484	-100%	-$2.52M	﹤0.01%	639
2020 Q2	$1.94M	Buy	171,535 +171,533	+8,576,650%	+$1.71M	0.52%	60
2020 Q1	$16	Hold	2	–	–	﹤0.01%	693
2019 Q4	$28	Hold	2	–	–	﹤0.01%	672
2019 Q3	$31	Hold	2	–	–	﹤0.01%	645
2019 Q2	$34	Sell	2 -1	-33%	-$17	﹤0.01%	655
2019 Q1	$54	Hold	3	–	–	﹤0.01%	594
2018 Q4	$38	Hold	3	–	–	﹤0.01%	654
2018 Q3	$55	Hold	3	–	–	﹤0.01%	641
2018 Q2	$66	Hold	3	–	–	﹤0.01%	629
2018 Q1	$55	Hold	3	–	–	﹤0.01%	570
2017 Q4	$63	Sell	3 -74,034	-100%	-$1.58M	﹤0.01%	559
2017 Q3	$1.82M	Buy	74,037 +65,806	+799%	+$1.58M	0.34%	53
2017 Q2	$191K	Sell	8,231 -1,513	-16%	-$32.6K	0.04%	204
2017 Q1	$202K	Buy	+9,744	New	+$207K	0.05%	193

Other funds holding HBI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's HBI Position: Q4 2020 in Review

Exane Derivatives sold out of Hanesbrands (HBI) in Q4 2020, closing a stake of 51 shares — an estimated $769 sold.

Exane Derivatives first reported a position in HBI in Q1 2017 and held it in 15 quarters. The position peaked at $1.94M in Q2 2020. 565 funds tracked by Wall St. Rank hold HBI as of Q4 2020.

Exane Derivatives reported no remaining Hanesbrands position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 51 Hanesbrands shares in Q4 2020, an estimated $769.
Exane Derivatives first reported a position in Hanesbrands in Q1 2017 and held it in 15 quarters.
Exane Derivatives's Hanesbrands position peaked at $1.94M in Q2 2020.
565 funds tracked by Wall St. Rank held Hanesbrands as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.